SEC Form 4 · accession 0001209191-17-040629

EXA CORP · EXA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 14, 2017

Accepted (ET)

Jun 16, 2017 · 5:56 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000890264

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 14, 2017	M	6,097	—	A	66,574	D
Common Stock^F2	holding	—	—		—	15,300	I	See footnote
Common Stock^F3	holding	—	—		—	50,192	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F4	—	Jun 14, 2017	M	6,097	D	—	—	Common Stock	6,097	0	D

F1Upon vesting, each restricted stock unit converts into one share of Exa common stock.
F2Represents shares purchased for a trust account over which the reporting person exercises investment control. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3Shares held by Poduska Family Limited Partnership II. Belmont Management Corporation of which the reporting person's five adult children own all the issued and outstanding shares, is the general partner of Poduska Family Limited Partnership II. The reporting person, under an agreement between Belmont Management Corporation and Eagle's Nest Scientific, Inc., which is wholly owned by the reporting person and of which the reporting person is the president, treasurer and sole director, exercises sole voting and investment power over the shares held by Poduska Family Limited Partnership II.
F4On June 14, 2016, the reporting person was granted 6,097 restricted stock units that vested in full on June 14, 2017.